Cargando…
艾曲波帕治疗异基因造血干细胞移植后难治性血小板减少的临床研究
OBJECTIVE: To evaluate the efficacy and safety of eltrombopag in post-HSCT thrombocytopenia. METHODS: A total of 10 patients who underwent post-HSCT thrombocytopenia at Peking University center, who had been treated with eltrombopag, were retrospectively evaluated. RESULTS: Of the 10 cases, 5 males...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348487/ https://www.ncbi.nlm.nih.gov/pubmed/28088971 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.12.011 |